跳至主要内容
临床试验/NCT00636181
NCT00636181已完成不适用

Positive Airway Pressure Initiation: Impact of Therapy Mode and Titration Process on Adherence and Outcomes

Philips Respironics10 个研究点 分布在 2 个国家目标入组 168 人开始时间: 2008年1月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
168
试验地点
10
主要终点
Apnea-Hypopnea Index

研究概览

简要总结

Six month at home positive pressure therapy study; which mode of therapy will lead to better adherence and patient outcomes?

详细描述

Three arm randomized controlled trial evaluating therapy titration methodologies and device comfort.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
21 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 21 - 75
  • Diagnosis of OSAHS with baseline AHI (Apnea-Hypopnea Index) equal or greater than 15 events/hr of sleep
  • Able and willing to provide written informed consent
  • Agreement to try PAP (positive airway pressure) as initial treatment approach
  • Adequate clinical CPAP titration within two weeks of enrollment

排除标准

  • Participation in another interventional research study within the last 30 days
  • The need for more than one titration PSG (polysomnography)
  • The use of sedatives or hypnotics during the titration PSG
  • Major medical or psychiatric condition that would interfere with the demands of the study, adherence to PAP or the ability to commit to follow-up assessment.
  • Prior prescription for, or exposure to PAP therapy within the previous year (except exposure to CPAP during clinical therapy titration.)
  • Chronic respiratory failure or insufficiency with suspected or known neuromuscular disease, moderate or severe COPD (chronic obstructive pulmonary disease) or other pulmonary disorders, or any condition with an elevation of arterial carbon dioxide levels (>45 mmHG) while awake or participants qualifying for oxygen therapy (arterial saturation < or equal to 88% for more than five minutes).
  • Surgery of the upper airway, nose, sinus, or middle ear within the previous 90 days
  • Surgery at any time for the treatment of OSAHS such as uvulopalatopharyngoplasty (UPPP)
  • Presence of untreated or poorly managed, non-OSAHS related sleep disorders:
  • moderate to severe periodic limb movements (greater or equal to 15 per hour with symptoms or arousals)
  • Restless Leg syndrome (greater than 10 per hour)
  • Males experiencing chronic insomnia
  • Use of medications with hypnotic or sedative effects or regular use of night time sedatives or sleeping aids greater than or equal to one night per week.
  • Consumption of ethanol more than 4 nights per week (CAGE criteria)
  • Shift workers

研究组 & 干预措施

Auto Aflex

Active Comparator

auto adjusting positive pressure therapy with AFLEX

干预措施: Auto AFlex (Device)

Auto CPAP

Active Comparator

auto adjusting positive pressure therapy

干预措施: Auto CPAP (Device)

CPAP

Active Comparator

continuous positive airway pressure

干预措施: CPAP (Device)

结局指标

主要结局

Apnea-Hypopnea Index

时间窗: Baseline and 180 Days

The Apnea-Hyopnea Index is the number of average number of apneas (complete pauses in breathing lasting at least 10 seconds) and hypopneas (decreases in airflow lasting at least 10 seconds) per hour of sleep. This data was compared from the polysomnography (sleep study) data after the first night of device use and at 180 days

次要结局

  • Average Hours of Nightly Use.(180 days)
  • Psychomotor Vigilance Task - Number of Lapses(Baseline and 180 Days)
  • Functional Outcomes of Sleep Questionnaire (FOSQ)(Baseline and 180 Days)
  • Attitudes Toward Use(Baseline and 180 Days)
  • Subjective Assessment of Therapy Comfort.(30, 90, and 180 days)
  • Epworth Sleepiness Scale(Baseline and 180 days)

研究者

申办方类型
Industry
责任方
Principal Investigator
主要研究者

Clete Kushida

Professor

Stanford University

研究点 (10)

Loading locations...

相似试验